Peer Review History

Original SubmissionDecember 5, 2023
Decision Letter - Claudia Garcia Serpa Osorio-de-Castro, Editor

PONE-D-23-39952Strengthening research networks: insights from a nationwide clinical research network in BrazilPLOS ONE

Dear Dr. Fonseca,

Thank you for submitting your manuscript to PLOS ONE. I am happy to send you the Reviewer Comments and apologize again for the time in review.  After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. 

Please submit your revised manuscript by Jul 19 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Claudia Garcia Serpa Osorio-de-Castro, Ph.D

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In the online submission form you indicate that your data is not available for proprietary reasons and have provided a contact point for accessing this data. Please note that your current contact point is a co-author on this manuscript. According to our Data Policy, the contact point must not be an author on the manuscript and must be an institutional contact, ideally not an individual. Please revise your data statement to a non-author institutional point of contact, such as a data access or ethics committee, and send this to us via return email. Please also include contact information for the third party organization, and please include the full citation of where the data can be found.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The article presents a relevant topic and makes a contribution to network analysis. The materials and methods section requires revision, as the order is not in a logical chronology. It is suggested to start with the study design, participants, construction of the questionnaire, dimensions analysis and forms of analysis.

Reviewer #2: General comments

This paper assessing a clinical research network in Brazil is interesting, given the importance to describe and evaluate such networks. Parts of the analyses are mainly of local/regional interest, while others are generalizable. I believe, however, that there is room for improvement in the context description and discussion to add value for readers in other settings.

Specific comments for revision

a) Major

Abstract: Number of respondents and response rate is not presented in the abstract

Abstract & introduction: I lack a clearly formulated aim, both in the abstract and in the end of the introduction section. The message is there, but it could be described more clear, also potentially including a few specific research questions.

Introduction: It could be further stressed how this network benefits both research and healthcare. It would also be valuable with more comparisons with similar networks in other settings. What are the key features of this network and how does it differ from others regarding management, staffing, aims, structure, and the way how it integrates academy with clinical care.

Introduction: I is claimed that they started some ten years ago, and such networks take time to develop. It would be valuable to get some description of the time line, and important milestones.

Methods :Page 9-10 incl Fig 2. This description of the population is very valuable but should come earlier, preferably first in the methods section directly as setting or population. It is also possible to place it in the introduction together with a more comprehensive description of the network.

Methods/results: No statistical measure of uncertainty has been applied, e.g. adding confidence intervals on proportions and comparisons. Overall I cant see that many comparisons between groups. Perhaps this is wise given the small numbers, but it might have been interesting to see differences in responses based on respondent categories (with an appropriate statistical test)

Results: The initial sentence “questionnaire was accessed by”, does it mean that this number was invited?

Results: There are many illustrations – in total 6 figures and 5 tables. I don’t know the maximum allowed number by the journal, but suggest some could be moved to appendices

Discussion: The structure could be improved through adding a first sharp paragraph about the key findings, then more integration between the assessment of own findings in relation to others. Overall, the generalizability and and comparisons with what is known in the scientific literature should be emphasized more to increase the value for the global scientific community.

Discussion: There is a lack of a Strengths and weaknesses section, which is a necessary part of a discussion.

b) Minor

There are no subheadings in Abstract (Intro, Aim, Methods, Result, Discussion). I don’t know whether it is required by the journal or not, but think it would add value.

Texts: Some subheaders have different sizes. There is also some unnecessary repetition in the text (e.g. the response rate that comes twice) and quite a lot of numbers presented in double both in a table and in the free text. The results and discussion parts could therefore be revised and shortened slightly. I also recommend some statements to be modified to emphasize they are perceived by responders.

Table 5 –Abbreviations should be explained in footer

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

We thank the reviewers for their interest and useful comments on the manuscript.

REVIEWER 1

Comment: The article presents a relevant topic and makes a contribution to network analysis. The materials and methods section requires revision, as the order is not in a logical chronology. It is suggested to start with the study design, participants, construction of the questionnaire, dimensions analysis and forms of analysis.

Response: The methodology is now in a logical chronological order, as suggested.

REVIEWER 2

Comment: This paper assessing a clinical research network in Brazil is interesting, given the importance to describe and evaluate such networks. Parts of the analyses are mainly of local/regional interest, while others are generalizable. I believe, however, that there is room for improvement in the context description and discussion to add value for readers in other settings.

Response: Context description and discussion were improved to add value to the paper, as suggested. See the following comments.

Comment: Abstract: Number of respondents and response rate is not presented in the abstract

Response: The information was included, as suggested. See lines 31 and 32.

Comment: Abstract & introduction: I lack a clearly formulated aim, both in the abstract and in the end of the introduction section. The message is there, but it could be described more clear, also potentially including a few specific research questions.

Response: The aim of the study is now clearer and included in the abstract and introduction, as suggested. See lines 21 to 26 and 121 to 128

Comment: Introduction: It could be further stressed how this network benefits both research and healthcare. It would also be valuable with more comparisons with similar networks in other settings. What are the key features of this network and how does it differ from others regarding management, staffing, aims, structure, and the way how it integrates academy with clinical care.

Response: RFPC was better contextualized, and its benefits made clearer for research and healthcare. See lines 89 to 102

Comment: Introduction: I is claimed that they started some ten years ago, and such networks take time to develop. It would be valuable to get some description of the time line, and important milestones.

Response: RFPC’s milestones were included in the introduction, as suggested. See lines 103 to 110.

Comment: Methods :Page 9-10 incl Fig 2. This description of the population is very valuable but should come earlier, preferably first in the methods section directly as setting or population. It is also possible to place it in the introduction together with a more comprehensive description of the network.

Response: The information on the population was transferred to the first part of the methods section, as suggested. See lines 143 to 146. A more comprehensive description of the network was provided in the Introduction. See lines 89 to 102.

Comment: Methods/results: No statistical measure of uncertainty has been applied, e.g. adding confidence intervals on proportions and comparisons. Overall I cant see that many comparisons between groups. Perhaps this is wise given the small numbers, but it might have been interesting to see differences in responses based on respondent categories (with an appropriate statistical test)

Response: The aim of our study was to provide a descriptive and exploratory analysis. We did not attempt to compare groups due to the heterogeneity of categories and varying numbers of professionals. While group comparisons may be intriguing, we do not believe they are relevant for the overall analysis. Our focus is on tailoring RFPC for the entire community, rather than just one specific group.

Comment: Results: The initial sentence “questionnaire was accessed by”, does it mean that this number was invited?

Response: The questionnaire was distributed to all clinical research professionals at Fiocruz. Out of the 242 professionals who clicked on the link to access the questionnaire, 122 provided valid responses. This information is now documented in the Methods and Results section. See lines 181, 238 and 239.

Comment: Results: There are many illustrations – in total 6 figures and 5 tables. I don’t know the maximum allowed number by the journal, but suggest some could be moved to apêndices

Response: Figure 4, Table 4 and Table 5 were moved to Supplementary Material, as suggested. The article has now 5 figures and 3 tables.

Comment: Discussion: The structure could be improved through adding a first sharp paragraph about the key findings, then more integration between the assessment of own findings in relation to others. Overall, the generalizability and and comparisons with what is known in the scientific literature should be emphasized more to increase the value for the global scientific community.

Response: Discussion was improved as suggested. See lines 341 to 350, 354 to 356, 379 to 381, 416 to 417 and 421 to 423.

Comment: Discussion: There is a lack of a Strengths and weaknesses section, which is a necessary part of a discussion.

Response: A section on the study’s strengths and limitations section was added, as suggested. See lines 438 to 457.

Comment: There are no subheadings in Abstract (Intro, Aim, Methods, Result, Discussion). I don’t know whether it is required by the journal or not, but think it would add value.

Response: PLOS One guidelines do not require subheadings in the Abstract, but this section was amended to make the text clearer for the reader.

Comment: Texts: Some subheaders have different sizes. There is also some unnecessary repetition in the text (e.g. the response rate that comes twice) and quite a lot of numbers presented in double both in a table and in the free text. The results and discussion parts could therefore be revised and shortened slightly. I also recommend some statements to be modified to emphasize they are perceived by responders.

Response: The subheadings have been arranged in accordance with the journal's guidelines. In order to reduce redundancy of numbers in both the text and tables, we have condensed the results section as recommended.

Comment: Table 5 –Abbreviations should be explained in footer

Response: Table 5 has been moved to the supplementary material and the abbreviations have been included in the footer as suggested

Attachments
Attachment
Submitted filename: Response to reviewers.docx
Decision Letter - Claudia Garcia Serpa Osorio-de-Castro, Editor

Strengthening research networks: insights from a clinical research network in Brazil

PONE-D-23-39952R1

Dear Dr. Fonseca,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Claudia Garcia Serpa Osorio-de-Castro, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Claudia Garcia Serpa Osorio-de-Castro, Editor

PONE-D-23-39952R1

PLOS ONE

Dear Dr. Fonseca,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Claudia Garcia Serpa Osorio-de-Castro

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .